Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.

MLA

López-Hernández, Yamilé, et al. “Targeted Metabolomics Identifies High Performing Diagnostic and Prognostic Biomarkers for COVID-19.” Scientific Reports, vol. 11, no. 1, July 2021, p. 14732. EBSCOhost, https://doi.org/10.1038/s41598-021-94171-y.

APA

López-Hernández, Y., Monárrez-Espino, J., Oostdam, A.-S. H., Delgado, J. E. C., Zhang, L., Zheng, J., Valdez, J. J. O., Mandal, R., González, F. de L. O., Moreno, J. C. B., Trejo-Medinilla, F. M., López, J. A., Moreno, J. A. E., & Wishart, D. S. (2021). Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Scientific Reports, 11(1), 14732. https://doi.org/10.1038/s41598-021-94171-y

Chicago

López-Hernández, Yamilé, Joel Monárrez-Espino, Ana-Sofía Herrera-van Oostdam, Julio Enrique Castañeda Delgado, Lun Zhang, Jiamin Zheng, Juan José Oropeza Valdez, et al. 2021. “Targeted Metabolomics Identifies High Performing Diagnostic and Prognostic Biomarkers for COVID-19.” Scientific Reports 11 (1): 14732. doi:10.1038/s41598-021-94171-y.